ProShare Advisors’s Neurogene NGNE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Sell |
|
|||||
|
2022
Q1 | $20K | Sell |
|
|||||
|
2021
Q4 | $67K | Buy |
|
|||||
|
2021
Q3 | $98K | Sell |
|
|||||
|
2021
Q2 | $155K | Buy |
|
|||||
|
2021
Q1 | $177K | Buy |
|
|||||
|
2020
Q4 | $192K | Buy |
|
|||||
|
2017
Q4 | – | Sell |
|
|||||
|
2017
Q3 | $188K | Buy |
|
|||||
|
2017
Q2 | $169K | Sell |
|
|||||
|
2017
Q1 | $209K | Sell |
|
|||||
|
2016
Q4 | $255K | Buy |
|
|||||
|
2016
Q3 | $145K | Sell |
|
|||||
|
2016
Q2 | $85K | Buy |
|
|||||
|
2016
Q1 | $112K | Sell |
|
|||||
|
2015
Q4 | $173K | Buy |
|